Literature DB >> 18566514

Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set.

Amandeep K Dhillon1, Robyn L Stanfield, Miroslaw K Gorny, Constance Williams, Susan Zolla-Pazner, Ian A Wilson.   

Abstract

Although antibodies against the third variable loop (V3) of the HIV-1 viral envelope glycoprotein are among the first neutralizing antibodies to be detected in infected individuals, they are normally restricted in their specificity. X-ray crystallographic studies of V3-specific antibodies have contributed to a more thorough understanding of recognition of this epitope and of conserved features in the V3 loop that could potentially aid in the design of a multi-component vaccine. The human antibody 447-52D exhibits relatively broad neutralization of primary viral isolates compared with other V3-loop antibodies. A crystal structure of Fab 447-52D in complex with a V3 peptide (UG1033) was determined at 2.1 angstroms resolution. The structure was determined using an epitaxially twinned data set and in-house programs to detect and remove overlapping reflections. Although the processed data have lower than desired completeness and slightly higher than normal R values for the resolution, good-quality electron-density maps were obtained that enabled structure determination. The structure revealed an extended CDR H3 loop that forms a beta-sheet with the peptide, with the predominant contacts being main-chain hydrogen bonds. The V3 peptide and Fab show high structural homology with the previously reported structures of other Fab 447-52D complexes, reinforcing the idea that the V3 loop may adopt a small set of conserved structures, particularly around the crown of the beta-hairpin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566514      PMCID: PMC2631122          DOI: 10.1107/S0907444908013978

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  60 in total

1.  Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.

Authors:  R Stanfield; E Cabezas; A Satterthwait; E Stura; A Profy; I Wilson
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

2.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

3.  Complete nucleotide sequences of functional clones of the AIDS virus.

Authors:  L Ratner; A Fisher; L L Jagodzinski; H Mitsuya; R S Liou; R C Gallo; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

4.  Satisfying hydrogen bonding potential in proteins.

Authors:  I K McDonald; J M Thornton
Journal:  J Mol Biol       Date:  1994-05-20       Impact factor: 5.469

5.  Major antigen-induced domain rearrangements in an antibody.

Authors:  R L Stanfield; M Takimoto-Kamimura; J M Rini; A T Profy; I A Wilson
Journal:  Structure       Date:  1993-10-15       Impact factor: 5.006

Review 6.  HIV-1 envelope determinants for cell tropism and chemokine receptor use.

Authors:  T L Hoffman; R W Doms
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

7.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

8.  Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.

Authors:  Robyn L Stanfield; Jayant B Ghiara; Erica Ollmann Saphire; Albert T Profy; Ian A Wilson
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

9.  N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.

Authors:  Ruth A McCaffrey; Cheryl Saunders; Mike Hensel; Leonidas Stamatatos
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  19 in total

1.  Conserved structural elements in the V3 crown of HIV-1 gp120.

Authors:  Xunqing Jiang; Valicia Burke; Maxim Totrov; Constance Williams; Timothy Cardozo; Miroslaw K Gorny; Susan Zolla-Pazner; Xiang-Peng Kong
Journal:  Nat Struct Mol Biol       Date:  2010-07-11       Impact factor: 15.369

2.  Rotational order-disorder structure of fluorescent protein FP480.

Authors:  Sergei Pletnev; Kateryna S Morozova; Vladislav V Verkhusha; Zbigniew Dauter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-08-06

3.  An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.

Authors:  Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister
Journal:  Virology       Date:  2010-03-26       Impact factor: 3.616

4.  Computational-guided determination of the functional role of 447-52D long CDRH3.

Authors:  Edwin Kamau; Richard Bonneau; Xiang-Peng Kong
Journal:  Protein Eng Des Sel       Date:  2018-12-01       Impact factor: 1.650

5.  Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.

Authors:  Moumita Dutta; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

6.  The rotational order-disorder structure of the reversibly photoswitchable red fluorescent protein rsTagRFP.

Authors:  Sergei Pletnev; Fedor V Subach; Vladislav V Verkhusha; Zbigniew Dauter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-12-24

Review 7.  Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.

Authors:  Susan Zolla-Pazner; Timothy Cardozo
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

8.  HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.

Authors:  Paul W Keller; Orrianne Morrison; Russell Vassell; Carol D Weiss
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

9.  Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop.

Authors:  David Almond; Tetsuya Kimura; XiangPeng Kong; James Swetnam; Susan Zolla-Pazner; Timothy Cardozo
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

10.  Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1-infected humans.

Authors:  Ruimin Pan; Jared M Sampson; Yuxin Chen; Michael Vaine; Shixia Wang; Shan Lu; Xiang-Peng Kong
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.